| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/15/2005 | WO2005064020B1 Multiplexed nucleic acid analysis with high specificity |
| 09/15/2005 | WO2005064019A3 Universal amplification of fragmented rna |
| 09/15/2005 | WO2005059162A3 Microbial detection and quantification |
| 09/15/2005 | WO2005059037B1 Reagent for detecting an analyte |
| 09/15/2005 | WO2005056817A3 Method for recovering microorganisms from a sample |
| 09/15/2005 | WO2005055925A8 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types |
| 09/15/2005 | WO2005055812A3 Serum biomarkers for chagas disease |
| 09/15/2005 | WO2005054505A3 Method for detecting nucleic acid sequence variations |
| 09/15/2005 | WO2005052127A3 Real-time detection of nucleic acids and proteins |
| 09/15/2005 | WO2005049856A3 Methods and apparatus for the rapid detection of microorganisms collected from infected sites |
| 09/15/2005 | WO2005047898A3 Methods and compositions for identifying therapeutic compounds |
| 09/15/2005 | WO2005047545A3 Microarray controls |
| 09/15/2005 | WO2005045437A3 Method for distinguishing immunologically defined all subtypes |
| 09/15/2005 | WO2005044982A3 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 09/15/2005 | WO2005044077A3 Assay for acetyltransferases and acetyltransferase substrates |
| 09/15/2005 | WO2005043167A3 Method for distinguishing aml subtypes with differents gene dosages |
| 09/15/2005 | WO2005043154A3 High density reaction chambers and methods of use |
| 09/15/2005 | WO2005040428A3 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 09/15/2005 | WO2005038459A3 Bridged element for detection of a target substance |
| 09/15/2005 | WO2005036168A3 Method of detecting biological materials in liquid |
| 09/15/2005 | WO2005035788A3 Method and kit for assessing anxiety or disposition thereto in a subject |
| 09/15/2005 | WO2005031350A3 Human protein acyl transferases and methods of uses therefor |
| 09/15/2005 | WO2005028676A3 Method of diagnosing breast cancer |
| 09/15/2005 | WO2005024067A3 Genetic analysis for stratification of breast cancer risk |
| 09/15/2005 | WO2005023837A3 Ebola peptides and immunogenic compositions containing same |
| 09/15/2005 | WO2005019249A3 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 09/15/2005 | WO2005016256A3 Hemostatic compositions containing sterile thrombin |
| 09/15/2005 | WO2005015161A3 Imaging regulated protein-protein interactions in cells and living animals by enhanced luciferase protein fragment complementation |
| 09/15/2005 | WO2005012579A3 Homodimeric cyanine dye dimer comprising aromatic, heteroaromatic, cyclic or heterocyclic linker moiety in nucleic acid reporter molecules |
| 09/15/2005 | WO2005012499A3 Methods for amplifying polymeric nucleic acids |
| 09/15/2005 | WO2005010213A3 Markers for detection of gastric cancer |
| 09/15/2005 | WO2005007871A3 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 09/15/2005 | WO2005007663A9 Fluorogenic enzyme substrates and uses thereof |
| 09/15/2005 | WO2004111200A3 Rtvp-glipr-like compositions and methods for the detection, treatment and prevention of prostate cancer |
| 09/15/2005 | WO2004096997A3 Molecular detection systems utilizing reiterative oligonucleotide synthesis |
| 09/15/2005 | WO2004094606A3 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2 |
| 09/15/2005 | WO2004089284A3 Targets for tumor growth inhibition |
| 09/15/2005 | WO2004084711A3 Methods of detecting neurological disorders |
| 09/15/2005 | WO2004083449A3 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| 09/15/2005 | WO2004047764A3 Modulation of hiv replication by rna interference |
| 09/15/2005 | WO2004020586A3 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation |
| 09/15/2005 | WO2004016644A3 Compositions and methods used for identifying factors required for the agglomeration of proteins |
| 09/15/2005 | WO2003101400A3 Cancer-linked gene as target for chemotherapy |
| 09/15/2005 | WO2003000844A3 Protein modification and maintenance molecules |
| 09/15/2005 | WO2002048388A3 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 09/15/2005 | US20050204427 Expression vector comprising transcription regulatory protein for use in enhancing heterologous gene expression in plants |
| 09/15/2005 | US20050204419 Expression vector coding resistance polypeptide (RB) for use in transformation and geneation of disease resistant tomatoes and potatoes |
| 09/15/2005 | US20050204416 Plant cells having receptor polypeptides |
| 09/15/2005 | US20050204412 Artery- and vein-specific proteins and uses therefor |
| 09/15/2005 | US20050204410 SIRT6 transgenic non-human animals and assay methods |
| 09/15/2005 | US20050204409 Gene for identifying individuals with familial dysautonomia |
| 09/15/2005 | US20050204408 Imparting and/or enhancing glycosaminoglycan binding of water soluble protein via linkage of gene sequences to growth factors, cytokines and/or antibodies |
| 09/15/2005 | US20050203345 Articulating paddle elevator and arthroscopic method for using same |
| 09/15/2005 | US20050203282 For screening of agonists and antagonists of receptor which may have advantageous pharmaceutical or diagnostical properties; for identification of patients who may present genetic disorders induced by inactive receptor |
| 09/15/2005 | US20050203280 Nucleotide sequences coding gramnegative microorganismal genomic sequences for use as tool in diagnosing middle ear infection |
| 09/15/2005 | US20050203047 Methods for transcription and expression of nucleic acids into organisms; in particular, invention comprises a tRNA vector system to deliver and express short interfering nucleic acid, small interfering (siRNA), micro RNA (miRNA) and antisense (asRNA) into organism with high efficiency; pain treatment |
| 09/15/2005 | US20050203043 Identification of toxic nucleotide sequences |
| 09/15/2005 | US20050203041 Antisense compound and method for selectively killing activated T cells |
| 09/15/2005 | US20050203024 Peptides and methods for inducing cellular resistance to infection |
| 09/15/2005 | US20050203021 Identifying prorenin modulators for treatment of cardiovascular and organ hypertrophy; enzyme inhibitors; mimetics; blood pressure; arterial thickening |
| 09/15/2005 | US20050203018 Diagnosing hepatic disorders using aberrant growth hormone expression levels in liver |
| 09/15/2005 | US20050203014 Administering agonist of hedgehog signaling; attention deficit hyperactive disorders, non-Alzheimer dementia, and various symptoms of memory loss |
| 09/15/2005 | US20050203011 Increasing activity of glial cell line-derived neurotrophic factor (GDNF) or brain-derived neurotrophic factor (BDNF); alcohol abuse |
| 09/15/2005 | US20050202556 Process and spotting solution for preparing microarrays |
| 09/15/2005 | US20050202555 Cell detection chip and fabricating method thereof and cell detecting method |
| 09/15/2005 | US20050202549 Phosphodiesterase crystal for identifying modulators for use in treatment and prevention of sexual, pain and psychological disorders; drug screening and design |
| 09/15/2005 | US20050202548 Mammalian enzymatic polypeptide for use as tool in designing drugs which prevent and treat hypercholesterolemia, hyperlipemia, arteriosclerosis, parasitic infection, cell proliferative and vascular diseases |
| 09/15/2005 | US20050202540 Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene |
| 09/15/2005 | US20050202532 Amino acid sequences for prevention and treatment of cardiovascular disease |
| 09/15/2005 | US20050202523 fast detection and enumeration of low concentration of viable microorganisms using organic or inorganic substances that are entrapped in porous sol-gel glass |
| 09/15/2005 | US20050202522 Using feast/famine regulatory proteins (FFRPs) as tool in screening for micobiocide and/or bactericides |
| 09/15/2005 | US20050202521 Using glutathione, lipid peroxide and pyroglutamic acid blood plasma concentrations as diagnostic tool for measuring a systems utilization efficiency of anti-oxidant |
| 09/15/2005 | US20050202519 Mutated abl kinase domains |
| 09/15/2005 | US20050202518 Method for detecting and counting micro-organisms in a sample |
| 09/15/2005 | US20050202511 AMP-activated protein kinase (AMPK) inhibitor screening assay |
| 09/15/2005 | US20050202505 Using oxidoreductase to determine inhibitory effects of 2-acetylbenzofuran; diagnosis and treatment of psychological disorders |
| 09/15/2005 | US20050202503 Displacement assay for detection of small molecules |
| 09/15/2005 | US20050202501 Using sequencing by hybridization as tool in detecting variance in genic sequences; identifying restriction fragment length polymorphism and/or single nucleotide polymorphisms |
| 09/15/2005 | US20050202500 Using solid support comprising a multiplicity of immobilized probes as tool to determine transcript abundance in gene expression analysis; diagnosing cell proliferative disorders |
| 09/15/2005 | US20050202499 Reagents and methods useful for detecting diseases of the breast |
| 09/15/2005 | US20050202496 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/15/2005 | US20050202495 Hybridization probe and target nucleic acid detecting kit, target nucleic acid detecting apparatus and target nucleic acid detecting method using the same |
| 09/15/2005 | US20050202494 Catalases |
| 09/15/2005 | US20050202493 Method and apparatus for arranging liquid reaction components on substrate surface for detecting target substance by reaction among plural reaction components on substrate and article utilized in the method |
| 09/15/2005 | US20050202492 Microarray having probe polynucleotide spots capable of binding to the same target polynucleotide fragment maximally separated from each other and a method of producing the same |
| 09/15/2005 | US20050202491 Mixture comprising corrosion-inhibiting, wetting, solubilizing and nucleic acid deactivating agents for use as tool in transcription-based amplification assays |
| 09/15/2005 | US20050202490 Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation |
| 09/15/2005 | US20050202489 Method and apparatus for amplifying nucleic acids |
| 09/15/2005 | US20050202488 Assay for therapies that inhibit expression of the cytosolic Cu/Zn superoxide dismutase (SOD1) gene |
| 09/15/2005 | US20050202487 Methods for isolation of bacteria from biological samples |
| 09/15/2005 | US20050202485 Hepatic specific tumor polypeptides; diagnosing cell proliferative disorders of liver |
| 09/15/2005 | US20050202484 Using probe to identify single nuclelotide polymorphism in bovine leptin gene (UASMS1) of selected cattle; animal husbandry; breeding cattle of preferential feed intake, growth rate, body weight, carcass merit and/or carcass composition |
| 09/15/2005 | US20050202483 ITPase gene polymorphisms associated with adverse durg reactions to azathioprine therapy |
| 09/15/2005 | US20050202482 CD38 splice variants and uses thereof |
| 09/15/2005 | US20050202480 Stabilization of linear double-stranded DNA in the presence of exonucleases |
| 09/15/2005 | US20050202479 Methods and materials relating to insulin growth factor-like (IGFL) polypeptides and polynucleotides |
| 09/15/2005 | US20050202477 Nucleic acid probe for use in screening and identifying grampositive bacteria |
| 09/15/2005 | US20050202476 Detection of microorganisms |
| 09/15/2005 | US20050202475 Using chimeric membrane protein as diagnostic/prognostic indicator of cell proliferative disorders |
| 09/15/2005 | US20050202474 Phosphodiesterases |